1 year return (CAGR)
-26.79%
PDS Biotechnology Corp Exchange (NASDAQ, USD)
PDSB
0.84
+0.04 (+4.45%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-46.87%
5 year return (CAGR)
-43.78%
10 year return (CAGR)
-42.38%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
47.12M
Price/Sales
-
Ent value
53.91M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-2.18%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.94 |
| Daily high | 0.97 |
| Daily low | 0.81 |
| Daily Volume | 16.9M |
| All-time high | 469.80 |
| 1y analyst estimate | 5.75 |
| Beta | 1.55 |
| EPS (TTM) | -0.60 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| PDSB | S&P500 | |
| Current price drop from All-time high | -99.82% | -0.56% |
| Highest price drop | -99.96% | -56.47% |
| Date of highest drop | 19 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -88.46% | -10.68% |
| Avg time to new high | 394 days | 12 days |
| Max time to new high | 2745 days | 1805 days |
News
